Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Atkinson

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
JAMA Dermatology|April 4, 2014
BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinibPhil McClenahan, Lynlee L Lin, Jean-Marie Tan, et al.
Emerging Infectious Diseases|June 5, 2003
Poor potential coverage for 7-valent pneumococcal conjugate vaccine, MalawiStephen B Gordon, Stonard Kanyanda, Amanda L Walsh, et al.
The Journal of Investigative Dermatology|April 7, 2026
Second primary invasive cutaneous melanomas in Queensland over 4 decadesDanny R Youlden, Victoria Atkinson, Mark B Pinkham, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlusVictoria Atkinson, Caroline Robert, Jean J Grob, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2022
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAF<sup>V600</sup> wild-type melanoma progressing on prior anti-programmed death-1 therapyShahneen Sandhu, Victoria Atkinson, Maria González Cao, et al.
Acta Haematologica|October 23, 2022
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic LeukemiaMelinda Burgess, Colm Keane, Josh Wd Tobin, et al.
The Lancet. Oncology|April 1, 2018
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 studyGeorgina V Long, Victoria Atkinson, Serigne Lo, et al.
European Heart Journal|August 13, 2013
Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activityGeoffrey Lee, Saurabh Kumar, Andrew Teh, et al.
Journal of Medical Imaging and Radiation Oncology|March 28, 2022
Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomesMihir D Shanker, Sidyarth Garimall, Nick Gatt, et al.
Cancers|May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced MelanomaKrisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
JAMA Dermatology|April 4, 2014
BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinibPhil McClenahan, Lynlee L Lin, Jean-Marie Tan, et al.
Emerging Infectious Diseases|June 5, 2003
Poor potential coverage for 7-valent pneumococcal conjugate vaccine, MalawiStephen B Gordon, Stonard Kanyanda, Amanda L Walsh, et al.
The Journal of Investigative Dermatology|April 7, 2026
Second primary invasive cutaneous melanomas in Queensland over 4 decadesDanny R Youlden, Victoria Atkinson, Mark B Pinkham, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlusVictoria Atkinson, Caroline Robert, Jean J Grob, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2022
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAF<sup>V600</sup> wild-type melanoma progressing on prior anti-programmed death-1 therapyShahneen Sandhu, Victoria Atkinson, Maria González Cao, et al.
Acta Haematologica|October 23, 2022
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic LeukemiaMelinda Burgess, Colm Keane, Josh Wd Tobin, et al.
The Lancet. Oncology|April 1, 2018
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 studyGeorgina V Long, Victoria Atkinson, Serigne Lo, et al.
European Heart Journal|August 13, 2013
Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activityGeoffrey Lee, Saurabh Kumar, Andrew Teh, et al.
Journal of Medical Imaging and Radiation Oncology|March 28, 2022
Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomesMihir D Shanker, Sidyarth Garimall, Nick Gatt, et al.
Cancers|May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced MelanomaKrisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Pageof 13